129 related articles for article (PubMed ID: 36646233)
21. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
Zhao E; Cheng Y; Yu C; Li H; Fan X
Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
[TBL] [Abstract][Full Text] [Related]
23. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
[TBL] [Abstract][Full Text] [Related]
24. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality.
Kim D; Manikat R; Shaikh A; Cholankeril G; Ahmed A
Eur J Clin Invest; 2024 Jan; 54(1):e14087. PubMed ID: 37638383
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H
Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688
[TBL] [Abstract][Full Text] [Related]
26. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity.
Krishnan A; Hadi Y; Alqahtani SA; Woreta TA; Fang W; Abunnaja S; Szoka N; Tabone LE; Thakkar S; Singh S
JAMA Netw Open; 2023 Apr; 6(4):e237188. PubMed ID: 37027156
[TBL] [Abstract][Full Text] [Related]
28. Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.
Zhou X; Li Y; Zhang X; Guan YY; Puentes Y; Zhang F; Speliotes EK; Ji L
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3156. PubMed ID: 30892820
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors of fatty liver in Portuguese adults.
Leitão J; Carvalhana S; Cochicho J; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Oliveiros B; Rodrigues V; Sousa R; Sampaio F; Carvalho A; Cortez-Pinto H
Eur J Clin Invest; 2020 Jun; 50(6):e13235. PubMed ID: 32289180
[TBL] [Abstract][Full Text] [Related]
30. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
[TBL] [Abstract][Full Text] [Related]
31. Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD).
Henry A; Paik JM; Austin P; Eberly KE; Golabi P; Younossi I; Henry L; Gerber L; Younossi ZM
Aliment Pharmacol Ther; 2023 Mar; 57(6):709-722. PubMed ID: 36380111
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
Zou B; Yeo YH; Nguyen VH; Cheung R; Ingelsson E; Nguyen MH
J Intern Med; 2020 Jul; 288(1):139-151. PubMed ID: 32319718
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort study.
Niriella MA; Kasturiratne A; Beddage TU; Withanage SA; Goonatilleke DC; Abeysinghe CP; De Mel RT; Balapitiya TL; De Silva ST; Dassanayake AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; de Silva HJ
Liver Int; 2020 Jan; 40(1):101-106. PubMed ID: 31472085
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
[TBL] [Abstract][Full Text] [Related]
35. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
Zhang X; Heredia NI; Balakrishnan M; Thrift AP
PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.
Golabi P; Paik J; Hwang JP; Wang S; Lee HM; Younossi ZM
Liver Int; 2019 Apr; 39(4):748-757. PubMed ID: 30597715
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic fatty liver disease burden: Australia, 2019-2030.
Adams LA; Roberts SK; Strasser SI; Mahady SE; Powell E; Estes C; Razavi H; George J
J Gastroenterol Hepatol; 2020 Sep; 35(9):1628-1635. PubMed ID: 32048317
[TBL] [Abstract][Full Text] [Related]
40. Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults.
Moss K; Dennis BB; Naji L; Ahmed A; Kim D
J Gastrointestin Liver Dis; 2023 Sep; 32(3):323-331. PubMed ID: 37774224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
